The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs of the National Institutes of Health (NIH) supported the development of 99 drugs from 1996-2020 — a total that includes 16 percent of all such treatments that made a “significant” advance over available medicines. This finding is just one of the impacts that the National Academies of Sciences, Engineering and Medicine (NASEM) attributes to the program in a new report.
{iframe}https://ssti.org/blog/report-nih-sbirsttr-program-supported-99-drugs-numerous-successful-companies-over-25-years?utm_source=SSTI+Weekly+Digest&utm_campaign=a94930deab-EMAIL_CAMPAIGN_2022_02_17_05_06&utm_medium=email&utm_term=0_ecf5992d4c-a94930deab-220137949{/iframe}